Cointime

Download App
iOS & Android

The Use of Blockchain to Fight Drug Counterfeiting in the Pharmaceutical Industry

Drug counterfeiting is a huge problem worldwide. The prevalence of counterfeit drugs is especially problematic in emerging markets, where regulatory controls are often lax, and the demand for cheap medicines is high.

In fact, it is estimated that counterfeit drugs make up 10% of the global market, costing the industry billions of dollars each year. Despite pharmaceutical companies’ best efforts, the booming counterfeiting market is always prepared to outsmart them in a game of cat and mouse. Keeping tabs on suppliers and verifying authentic supply chains has become quite challenging.

From lax regulation to global trends, the challenges of counterfeit drugs are ever evolving. The pharmaceutical industry feels this impact as healthcare costs rise worldwide; drug counterfeiting could soon become an epidemic if anti-counterfeit strategies aren’t implemented quickly and effectively. As globalization continues to open new markets with increased demand for pharmaceuticals, we must intervene before these nefarious practices spiral out of control.

But what if there were a way to fight back against these counterfeiters? That’s where blockchain comes in.

Infusing Blockchain in the Pharmaceutical Industry

The health sector has been abuzz with the news of blockchain technology coming to revolutionize pharmaceuticals — and its potential continues to drive widespread excitement as trials continue.

Blockchain technology is the ultimate data protector, offering a foolproof system against malicious hacking and corruption. Its decentralized network uses a secure sharing protocol so only authorized parties can access valuable information about products throughout their entire supply chain journey — from origin to consumer — ensuring that drugs stay safe in transit.

Blockchain is an Ideal Technology for Pharmaceutical Track and Trace

Blockchain is shaking up healthcare, allowing drug manufacturers to create a secure ecosystem where data security and quality are top-notch. Everyone involved can easily access the necessary information — never before has it been so easy or promising for healthcare professionals to benefit from such a revolutionary technology.

With the addition of serial numbers to a blockchain, products get an unchanging identity. This is then kept safe through two hallmarks of blocks — decentralization and checksums. Firstly, all involved parties must sign off on any changes made while heightened levels of accuracy are enabled by cryptographic hash functions that mean alterations can never be reversed.

This platform provides a safe and secure way to get pharmaceuticals and carry out transactions. Buyers, sellers, manufacturers — everyone can experience an expedited process free from unnecessary intermediaries. Traceability is guaranteed, so you won’t have to worry about unexpected changes.

Data Security

Blockchain technology provides a safe haven for safeguarding patients’ medical records. It keeps the data secure and grants only those with permission access to confidential information, ensuring people’s rights aren’t compromised. In addition, it helps combat counterfeit drugs by offering fair pricing that leaves no room for deception! The smart contracts on its permissioned blockchain are explicitly designed to prevent shady actors from accessing sensitive patient details.

Vendor credentialing

Blockchain technology provides rigorous vendor credentialing of drug suppliers to ensure patients receive the best medication quality and safety. This vital step verifies their trustworthiness before any purchases are made — ensuring the drugs they provide meet even health ministry standards.

Buyer assurance

Blockchain technology has given consumers the power to verify a drug’s authenticity with just one scan. Combining QR codes, RFID, and GPS tech makes it easier than ever for companies to identify counterfeit products. As a bonus, buyers can now check product history before purchasing — giving them peace of mind that what they’re getting is genuine merchandise.

Tracing and tracking

Thanks to blockchain technology, supply chain tracing and tracking have reached the next level. The origin of drugs can easily be identified along with a complete list of designated destinations each item is likely to pass through. Software-facilitated decentralization ensures smooth sailing while maintaining high product quality throughout the entire process — now that’s something worth celebrating.

Transparency

By leveraging the public ledger of blockchain tech, all parties have crystal-clear visibility throughout the drug supply chain. So no one needs to worry about a sudden change during transit as everyone involved in the supply process is ‘in the know.’ Everyone has access to essential product information, and any changes during shipping or receiving can be made with a few clicks. With this system in place, counterfeit drugs don’t stand a chance.

Closing Thoughts

The pharmaceutical industry is jumping on the blockchain bandwagon and ushering in a new era of drug serialization that is much more effective than its predecessors. From El Salvador legalizing Bitcoin as a legal tender to World Health Organization giving their support, it’s clear that this groundbreaking technology isn’t going anywhere anytime soon! With features like anonymity, decentralization, tamper-proofing, and transparency, efficient tracking of drugs will help end patient health risks for good.

Comments

All Comments

Recommended for you

  • Central Clearing Company Reduces Settlement Service Fee for Market Makers from 20% to 25% Discount

    On June 16, the Central Clearing Company announced that the Central Government Securities Registration and Settlement Co., Ltd. is seeking public opinions on further reducing the settlement service fees for market makers. In accordance with the requirements of the regulatory authorities to lower trading settlement costs for market makers, the Central Government Securities Registration and Settlement Co., Ltd. has decided to reduce the settlement service fee for transactions executed by market makers from a 20% discount to a 25% discount. The identification and recognition of genuine market-making transactions by market makers will be based on the transaction data transmitted to the company by the foreign exchange trading center. This preferential measure will be effective from July 1, 2026, until December 31, 2028.

  • Kioxia Sets New Record, Becomes Japan's Most Valuable Company with 807% Annual Increase

    On June 16, Japanese storage giant Kioxia closed up over 4% at 97,420 yen, reaching a new historical high. Its market capitalization has reached 51.75 trillion yen, solidifying its position as Japan's most valuable company. Kioxia has seen an increase of 807% year-to-date.

  • Nikkei Hits Record High, Up 37.87% Year-to-Date

    On June 16, the Nikkei 225 index briefly rose by 1% to 70,020.68 points, marking the first time it surpassed the 70,000-point threshold. It ultimately closed up 0.13% at 69,404.50 points, setting a new all-time closing high with a year-to-date increase of 37.87%. The Bank of Japan announced today that it will raise the policy interest rate by 25 basis points to 1%, the highest level in 31 years.

  • Bank of Japan Deputy Governor Shinichi Uchida: Japan's Economy Has Moderately Recovered

    Bank of Japan Deputy Governor Shinichi Uchida stated that Japan's economy has moderately recovered, although some sectors have shown signs of weakness. The central bank will continue to raise policy interest rates based on developments in economic activity, prices, and financial conditions.

  • Bank of Japan Deputy Governor Shinichi Uchida to Hold Monetary Policy Press Conference in Ten Minutes

    Bank of Japan Deputy Governor Shinichi Uchida will hold a monetary policy press conference in ten minutes.

  • WGC Survey: More Central Banks Plan to Increase Gold Reserves

    On June 16, the World Gold Council (WGC) announced that 45% of the central banks surveyed expect to increase their gold holdings in the next 12 months, up 2 percentage points from a year ago. In the annual survey conducted by the WGC from February 5 to May 19, 54% of the 74 central banks indicated that their gold holdings would remain unchanged, while 1% expected a decrease. Most responses were received after the outbreak of conflict in the Middle East in late February, which led to rising oil prices and a decline in gold prices. The WGC's global central bank director stated that central banks remain enthusiastic about gold, and the recent drop in gold prices has not changed their views. Furthermore, the WGC reported that 93% of respondents indicated they already hold gold, up from 81% a year ago. Among the various reasons for holding gold, as many as 90% of respondents cited gold's strong performance during times of crisis. Other key reasons include long-term value storage and portfolio diversification. Respondents from emerging markets and developing economies (85%) place greater emphasis on gold as a hedge against geopolitical risks. As some central banks continue to shift their gold reserves, 9% of respondents reported increasing their domestic gold reserves in the past 12 months, up from 5% last year; 10% indicated they have diversified their overseas gold reserve locations, up from 2% last year. In the next 12 months, 7% of central banks plan to increase domestic storage, and 9% plan to diversify overseas storage locations.

  • SpaceX's Market Value Surpasses $2.5 Trillion, Exceeding Total Cryptocurrency Market Value

    On June 16, SpaceX showed strong performance after its listing on Nasdaq, with its stock price rising significantly, increasing by 19.6% on the second trading day. Its market value has surpassed $2.5 trillion. According to Coingecko data, the total market value of the cryptocurrency market is approximately $2.34 trillion. SpaceX's market value now exceeds that of the entire cryptocurrency market.

  • AI Version of Alipay Officially Launched, Ant Group Concept Stocks Strengthen

    On June 16, Alipay officially launched its AI version, becoming the world's first super app to complete a full-scale AI transformation. On the day of the product launch, Ant Group concept stocks collectively strengthened, with rapid capital inflow and significant profit effects in the sector. As of now, several component stocks have risen over 3%. Among them, Nanwei Software and Hejing Technology have increased by over 5%, Jinshi Technology by over 4%, and Xiexin Energy by over 3%. From a strategic perspective, Alipay has already completed its positioning at the data level. Currently, the number of AI payment users has surpassed 100 million, and the total number of intelligent payment transactions has exceeded 300 million, making it the only large-scale commercial AI-native payment infrastructure globally. Industry insiders compare this event to the mobile payment revolution 12 years ago, when the industry landscape was rewritten due to WeChat's strategic positioning during the Spring Festival. Now, with Alipay taking the lead in fully establishing its presence in the AI era, it may signify a new phase in the competition for super app AI entry.

  • HYPE Surges Over 10% in a Day, Currently Priced at $71.569

    On June 16, market data showed that HYPE surged over 10% in a single day, currently priced at $71.569. Previously, there were reports that Arthur Hayes allegedly bought back 47,000 HYPE tokens.

  • DeepSeek Reportedly Completes Over $7 Billion Financing

    On June 16, according to The Information, DeepSeek has completed over $7 billion in financing, with this round valuing the company at over $50 billion.